CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

J&J shares down despite guidance raise as MedTech revenues disappoint

EarningsNegative
AI Analysis

Summary

Johnson & Johnson raised forward guidance but shares declined as MedTech revenues fell short of expectations in earnings reporting.

Financial Highlights

Guidance

raised

Importance:6/10
Sentiment:
-0.30
earningsguidancemedtechrevenue_miss
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on October 13, 2026 4:04 PM

Read Original